Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...

On June 27, 2024, the Court of King's Bench of Alberta issued the first decision interpreting the new streamlined trial process in Arsenault v. Big Rock Brewery Limited Partnership by its general ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

The research industry’s approach to building clinical trial equity and inclusion has shifted, bringing a renewed focus to these goals. This is great news: Trials that more accurately represent patient ...

Already since 31 January 2023 all applications for new clinical trials must be submitted under the legal framework of the Clinical Trials Regulation (Regulation EU/536/2014, CT Regulation). By 31 ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

In total, 5,251 discretized criteria were extracted from 216 protocols. The most frequent criterion was previous chemotherapy/biologics (17%). The multilabel SVM demonstrated a pooled accuracy of 75%.

A law school has recently embarked on an innovative experiment by conducting a mock trial with a jury composed entirely of artificial intelligence models. This unique setup featured three prominent AI ...